Short Bowel Syndrome – Causes, Symptoms & Treatment
Short bowel syndrome occurs after the loss of a large portion of the small intestine, leading to serious malabsorption of nutrients, fluids, and vitamins.
Things worth knowing about "Short Bowel Syndrome"
Short bowel syndrome occurs after the loss of a large portion of the small intestine, leading to serious malabsorption of nutrients, fluids, and vitamins.
What is Short Bowel Syndrome?
Short bowel syndrome (SBS) is a rare but serious condition of the digestive system that develops when a significant portion of the small intestine is absent or non-functional. The small intestine is responsible for absorbing nutrients, fluids, vitamins, and minerals. When a large part of it is missing, the body can no longer absorb these essential substances adequately -- a condition known as malabsorption.
Short bowel syndrome is generally diagnosed when fewer than 150 to 200 centimeters of functional small intestine remain. In newborns and children, adjusted thresholds apply based on body size and age.
Causes
Short bowel syndrome can be congenital (present at birth) or acquired. The most common causes include:
- Surgical removal of portions of the small intestine, for example due to Crohn disease, bowel obstruction, or intestinal cancer
- Mesenteric ischemia: Reduced blood supply to the intestine causing tissue death
- Radiation enteritis: Intestinal damage caused by radiation therapy
- Congenital malformations such as intestinal atresia (blockage of the bowel) or gastroschisis
- Necrotizing enterocolitis in premature infants
Symptoms
The symptoms of short bowel syndrome vary depending on which part of the small intestine is missing and how much remains. Common complaints include:
- Chronic, watery diarrhea
- Weight loss and malnutrition
- Dehydration
- Deficiencies in vitamins (e.g., vitamin B12, vitamin D) and minerals (e.g., calcium, magnesium, zinc)
- Fatigue and general weakness
- Bloating and abdominal cramps
- Fatty stools (steatorrhea)
- In children: growth retardation
Diagnosis
Diagnosis of short bowel syndrome is typically made through a combination of:
- Medical history and physical examination: Review of prior surgeries and clinical presentation
- Blood and laboratory tests: Measurement of nutrient levels, electrolytes, and inflammatory markers
- Imaging studies: X-rays, CT scans, or MRI to assess the remaining bowel structure and length
- Stool analysis: Evaluation of fat and nutrient content in the stool
Treatment
Treatment of short bowel syndrome is complex and must be tailored to the individual patient. The primary goals are to ensure adequate nutrition and to prevent complications.
Nutritional Therapy
In the acute phase, parenteral nutrition (intravenous delivery of nutrients directly into the bloodstream) is often required. Over time, the goal is to transition toward enteral nutrition (through the gastrointestinal tract) or oral food intake to stimulate intestinal function and adaptation.
Pharmacological Treatment
- Antisecretory agents (e.g., proton pump inhibitors) to reduce gastric acid production
- Antidiarrheal medications (e.g., loperamide) to slow intestinal transit
- Teduglutide: A GLP-2 analogue that promotes intestinal growth and improves absorptive function
- Supplementation of vitamins and minerals
Surgical Options
In selected cases, surgical procedures such as intestinal lengthening (STEP procedure or Bianchi operation) or small bowel transplantation may be considered.
Intestinal Adaptation
The remaining bowel has the capacity for adaptation: it can adjust during the first two years after surgery by increasing its surface area and improving its absorptive capacity. This adaptation phase is critical for the long-term outcome.
Prognosis and Living with Short Bowel Syndrome
The prognosis of short bowel syndrome depends strongly on the length and type of remaining bowel, the presence of the ileocecal valve and colon, and the underlying disease. Many patients require long-term or permanent parenteral nutrition. However, with modern medical care and interdisciplinary management, quality of life can be significantly improved.
References
- Pironi L et al. - ESPEN guidelines on chronic intestinal failure in adults. Clinical Nutrition, 2016; 35(2): 247-307.
- Jeppesen PB - Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with dependent short bowel syndrome. Therapeutic Advances in Gastroenterology, 2012; 5(3): 159-171.
- World Health Organization (WHO) - Malnutrition: Key Facts. Available at: https://www.who.int/news-room/fact-sheets/detail/malnutrition
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Short Bowel Syndrome-en